September 11, 2024

PhoreMost $12M Series B Financing to Advance Next-Gen Degrader Programs

Featured

PhoreMost, a UK-based biopharmaceutical firm, has raised an additional $12 million in its Series B funding round, bringing the total to over $50…

Biotech /

September 11, 2024

Solasta Bio Secures £10.7m to Advance Eco-Friendly Insecticide

Solasta Bio Raises £10.7m for Nature-Based Insecticide Development…

Biotech /

September 10, 2024

Bionano Genomics Layoffs Hit 45% of Staff, Reducing Workforce by 84 Employees

Bionano Genomics has announced a major reduction in its workforce, laying off 45% of its staff, or 84 employees, as part of a…

Biotech /

September 10, 2024

CardiaTec Raises $6.5M to Drive Computational Cardiovascular Drug Discovery

CardiaTec, a biotech company based in Cambridge, UK, has raised $6.5 million in seed funding to accelerate the development of its computational drug…

Biotech /

September 5, 2024

Tilray Lays Off 10 Barrel Brewing’s Entire Innovation Team Amidst Strategic Restructuring

Exclusive

Just over a year after the high-profile acquisition of 10 Barrel Brewing by Tilray, the company is facing a significant shake-up. Last week,…

Biotech /

September 3, 2024

ThinkCyte Raises $32M in Series C Funding

ThinkCyte Raises $32M in Series C Funding to Expand VisionSort™ Platform Globally …

Biotech / Healthcare /

September 3, 2024

Melodi Health Closes $10.75M Series A

Melodi Health, a Minneapolis-based medical device company, has announced two major milestones: the successful closing of an oversubscribed $10.75 million Series A financing…

Biotech /

August 26, 2024

Cloudbreak Health Acquires Voyce and Rebrands as Equiti

Cloudbreak Health, a Sunrise, FL-based provider of video remote interpretation services for the healthcare sector, has acquired Voyce, a tech-enabled language services provider….

Biotech / Healthcare /

August 23, 2024

Bicara Therapeutics Files for IPO to Fund R&D

Bicara Therapeutics, a Boston-based clinical-stage biopharmaceutical company specializing in treatments for solid tumors, has filed for an initial public offering (IPO) with the…

Biotech /

August 21, 2024

Pathalys Pharma Raises $105M in Series B Funding

Pathalys Pharma, a biopharmaceutical company based in Research Triangle Park, NC, has raised $105 million in Series B funding to support its late-stage…

Biotech /

September 11, 2024

PhoreMost $12M Series B Financing to Advance Next-Gen Degrader Programs

September 11, 2024

Solasta Bio Secures £10.7m to Advance Eco-Friendly Insecticide

September 10, 2024

Bionano Genomics Layoffs Hit 45% of Staff, Reducing Workforce by 84 Employees

September 10, 2024

CardiaTec Raises $6.5M to Drive Computational Cardiovascular Drug Discovery

September 5, 2024

Tilray Lays Off 10 Barrel Brewing’s Entire Innovation Team Amidst Strategic Restructuring

September 3, 2024

ThinkCyte Raises $32M in Series C Funding

September 3, 2024

Melodi Health Closes $10.75M Series A

August 26, 2024

Cloudbreak Health Acquires Voyce and Rebrands as Equiti

August 23, 2024

Bicara Therapeutics Files for IPO to Fund R&D

August 21, 2024

Pathalys Pharma Raises $105M in Series B Funding

Follow Silicon Valley Journals

Awarded by

Fundings

Quick links

Company